Business Description
Imunon Inc
NAICS : 325412
SIC : 2834
ISIN : US15117N5032
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.82 | |||||
Equity-to-Asset | 0.39 | |||||
Debt-to-Equity | 0.37 | |||||
Debt-to-EBITDA | -0.07 | |||||
Interest Coverage | N/A | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 39.6 | |||||
3-Year EPS without NRI Growth Rate | 36.6 | |||||
3-Year FCF Growth Rate | 33.6 | |||||
3-Year Book Growth Rate | -40.8 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 24.49 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 40.71 | |||||
9-Day RSI | 44.13 | |||||
14-Day RSI | 45.62 | |||||
6-1 Month Momentum % | 48.97 | |||||
12-1 Month Momentum % | 4.85 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.51 | |||||
Quick Ratio | 1.51 | |||||
Cash Ratio | 1.05 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -51.3 | |||||
Shareholder Yield % | 25.07 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -138.64 | |||||
ROA % | -91.04 | |||||
ROIC % | -657.81 | |||||
3-Year ROIIC % | 16.34 | |||||
ROC (Joel Greenblatt) % | -884.2 | |||||
ROCE % | -137.17 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 2.59 | |||||
Price-to-Tangible-Book | 2.54 | |||||
EV-to-EBIT | -0.56 | |||||
EV-to-Forward-EBIT | -0.4 | |||||
EV-to-EBITDA | -0.58 | |||||
EV-to-FCF | -0.58 | |||||
Price-to-Net-Current-Asset-Value | 5.88 | |||||
Earnings Yield (Greenblatt) % | -178.57 | |||||
FCF Yield % | -127.26 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Imunon Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -1.776 | ||
Beta | 1.44 | ||
Volatility % | 160.98 | ||
14-Day RSI | 45.62 | ||
14-Day ATR (€) | 0.063459 | ||
20-Day SMA (€) | 0.98075 | ||
12-1 Month Momentum % | 4.85 | ||
52-Week Range (€) | 0.438 - 3.7 | ||
Shares Outstanding (Mil) | 14.4 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 0 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Imunon Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Imunon Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Imunon Inc Frequently Asked Questions
What is Imunon Inc(FRA:CBO)'s stock price today?
When is next earnings date of Imunon Inc(FRA:CBO)?
Does Imunon Inc(FRA:CBO) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |